Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5322
Abstract: XPO1 mediates the nuclear export of several proteins, mainly tumor suppressors. KPT‐330 (Selinexor) is a selective inhibitor of XPO1 that has demonstrated good therapeutic effects in hematologic cancers.
read more here.
Keywords:
cell proliferation;
xpo1;
cholangiocarcinoma cell;
inhibition xpo1 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.15005
Abstract: Cholangiocarcinoma is a rare, but highly fatal malignancy. However, the intrinsic mechanism involved in its tumorigenesis remains obscure. An urgent need remains for a promising target for cholangiocarcinoma biological therapies. Based on comparative proteomical technologies,…
read more here.
Keywords:
cell;
apoptosis;
erk akt;
induction erk ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10051022
Abstract: Cholangiocarcinoma (CCA) is the second most common primary liver cancer with poor prognosis. The deregulation of a lot of oncogenic signaling molecules, such as receptor tyrosine kinases (RTKs), has been found to be associated with…
read more here.
Keywords:
hucct1;
migration;
src;
cholangiocarcinoma cell ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Chinese Medical Journal"
DOI: 10.4103/0366-6999.221271
Abstract: Background: Decoy receptor 3 (DcR3) is a protein with anti-apoptotic effect that belongs to the tumor necrosis factor receptor superfamily. DcR3 is highly expressed in a variety of malignant tumors including cholangiocarcinoma and its expression…
read more here.
Keywords:
cell line;
cell;
cholangiocarcinoma;
dcr3 ... See more keywords